Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients
Open Access
- 1 December 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 10 (6), 1025-1034
- https://doi.org/10.1215/15228517-2008-052
Abstract
The benefit of cytoreductive surgery for glioblastoma multiforme (GBM) is unclear, and selection bias in past series has been observed. The 5-aminoleKeywords
This publication has 27 references indexed in Scilit:
- EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORMENeurosurgery, 2008
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysisNeuro-Oncology, 2004
- Debulking or biopsy of malignant glioma in elderly people – a randomised studyActa Neurochirurgica, 2003
- Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST).Stroke, 1994
- Serial assessment of acute stroke using the NIH Stroke Scale.Stroke, 1994
- Early Postoperative Magnetic Resonance Imaging after Resection of Malignant GliomaNeurosurgery, 1994
- Early Postoperative Magnetic Resonance Imaging after Resection of Malignant Glioma: Objective Evaluation of Residual Tumor and Its Influence on Regrowth and PrognosisNeurosurgery, 1994
- The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients.Journal of Neurology, Neurosurgery & Psychiatry, 1990